Refine by
Liver Disease Suppliers & Manufacturers
82 companies found
based inParis, FRANCE
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for ...
The state-of-the-art non-invasive solution, affordable to all. Powered by LSM by VCTE™ and CAP™ for liver fibrosis and steatosis management. Supported by 6 270+ peer reviewed publications and 250+ guidelines. An ideal solution for ...
based inDoylestown, PENNSYLVANIA (USA)
ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology. The company’s primary products in development are innovative diagnostic biomarkers as ...
based inRochester, MINNESOTA (USA)
Cytotheryx, Inc. is a preclinical cell therapy company focused on the development of a readily available, consistent and high-quality source of primary human hepatocytes (liver cells) and the use of those cells for research and clinical ...
At Cytotheryx, we understand that life-saving discovery in liver disease research and medicine requires a multi-faceted approach. The key to enabling this innovation is a reliable foundation. We understand this need ...
based inGlasgow, UNITED KINGDOM
We’re a leading microbiome therapeutics company. We have established proprietary MHRA licensed manufacturing capabilities and a supply chain model that enables us to leverage a pipeline of internal and partnered programmes around our lead asset, ...
The gut-liver-brain axis describes the interplay of immune, metabolic and neuroendocrine biology that is increasingly being recognised as a potential therapeutic ...
based inVienna, AUSTRIA
ViennaLab Diagnostics specializes in easy-to-use in vitro diagnostic assays for the detection of genetic variants associated with genetic disorders, genetic predispositions, pharmacogenetics, cancer, and the human microbiome. Our focus is on product ...
Alpha-1 Antitrypsin (AAT) deficiency is an inherited disorder, which is still an underappreciated, but treatable cause of chronic obstructive pulmonary disease (COPD). The AAT RealFast™ Assay is designed for the simultaneous detection of ...
based inFoster City, CALIFORNIA (USA)
Gilead is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the ...
Ledipasvir 90 mg/sofosbuvir 400 mg. Harvoni® is indicated for the treatment of adults and pediatric patients ≥3 years with chronic hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis. ...
based inChantilly, VIRGINIA (USA)
Arthus Biosystems is pleased to provide a series of research reagents and kits to help carry out scientific investigations related to methionine cycle, the critical biochemical pathway that is conserved throughout evolution in all organisms. Our SAM ...
Methionine is an amino acid with sulfur methyl group, which is converted into S-adenosyl methionine (SAM) with ATP by methionine adenosyltransferase (EC 2.5.1 6). SAM is the sole methyl group donor to* over 50 kinds of biologically active substances ...
based inJenkintown, PENNSYLVANIA (USA)
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs. A completely new approach to drug ...
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
based inKyiv, UKRAINE
Darnitsa is the leader of the Ukrainian market in physical terms. 90 years of experience and GMP production certification have allowed us to earn confidence in 16 countries worldwide. We produce 180 products with a focus on cardiology, neurology, ...
Symbiia® - for treatment of major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety ...
based inLabège, FRANCE
Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...
Bacterial translocation: the missing link between intestinal microbiome and human complex non-communicable diseases. Complex disorders are multifactorial and often chronic, caused by genetic and environmental factors and comprising hundreds of ...
based inOldsmar, FLORIDA (USA)
VetBiotek provides innovative solutions for veterinary medicine. The VetBiotek management team has over 200 years of cumulative experience in the veterinary marketplace. Our goal is to bring the most advanced, novel ingredients to the veterinary ...
based inBrisbane, CALIFORNIA (USA)
Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. ...
Enhanced genome editing with an expanded CRISPR toolkit: Our CRISPR-Cas systems provide unprecedented power to edit the ...
based inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Ascites is also a common complication of certain late-stage cancers due to fluid build-up in the peritoneal cavity from a number of causes including draining of the lymph system. While life expectancy for many cancer patients with malignant ascites ...
based inFederal Way, WASHINGTON (USA)
Established in 1987, DiagnosTechs was the first laboratory to introduce saliva hormone testing into routine clinical practice. In 1995, DiagnosTechs added saliva and stool-based gastrointestinal and food sensitivity testing, which expanded the level ...
based inDwarka, INDIA
Everflow Global. We are a leading company engaged in water & air treatment using the bioremediation Process. We offer you the best technology in industrial wastewater treatment. Our cleantech solutions are focused on Carbon negative and ...
Astaxanthin pigment is produced by freshwater microalgae Haematococcus Pluvialis and also by some funguses. It is a keto-carotenoid group containing metabolites of zeaxanthin and canthaxanthin. Astaxanthin is well known for its antioxidant ...
based inDeventer, NETHERLANDS
From its location in the Netherlands, Kepro has been producing veterinary pharmaceuticals for livestock since 1972. Our products can be found in 85 countries worldwide, from Europe, Africa, the Middle East and Asia to Central and South America. We ...
Fatty liver test to determine fatty liver ...
based inFaridabad, INDIA
Medsource Ozone Biomedicals has been growing at a rapid annual pace establishing itself as perhaps the fastest growing In Vitro Diagnostics organization in the South Asian region. Today we are a 350 plus people organization with offices in Delhi and ...
Coagulation, also known as clotting, is the process by which blood changes from a liquid to a gel, forming a blood clot. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The mechanism of ...
based inLondon, UNITED KINGDOM
Applied Nanodetectors was formed in 2004 and is a leading developer and supplier of nanosensor based solutions for environmental, healthcare and medical worldwide markets. Improving peoples quality of life with our products. Dedicated to delivering ...
Exhale-Dx™ Is A Non-Invasive Point Of Care Device, That Implements Breath Analysis To Forecast Your Future Diagnosis. This Provides The Patient With Personalised ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
